SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-18-007139
Filing Date
2018-05-24
Accepted
2018-05-24 09:01:31
Documents
9
Period of Report
2018-05-23
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fcsc52418form8-krss.htm 8-K 46691
2 EXHIBIT 3.1 exhibit31certificate.htm EX-3.1 4689
3 EXHIBIT 99.1 ex991finalreversesplit.htm EX-99.1 8240
4 ex991finalreversesplit001.jpg GRAPHIC 242829
5 ex991finalreversesplit002.jpg GRAPHIC 227145
6 ex991finalreversesplit003.jpg GRAPHIC 33058
7 exhibit31certificate001.jpg GRAPHIC 156472
8 exhibit31certificate002.jpg GRAPHIC 31288
9 image0a17.jpg GRAPHIC 74382
  Complete submission text file 0001628280-18-007139.txt   1113269
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31564 | Film No.: 18856741
SIC: 2834 Pharmaceutical Preparations